Navigation Links
Brain Cancer Drug Pipeline Update 2012
Date:7/16/2012

- Catalytic activity

- Cell adhesion molecule activity

- Chaperone activity

- Complement activity

- Cysteine-type peptidase activity

- Cytokine activity

- DNA binding

- DNA repair protein

- DNA topoisomerase activity

- DNA-directed DNA polymerase activity

- Extracellular ligand-gated ion channel activity

- Extracellular matrix structural constituent

- G-protein coupled receptor activity

- Growth factor activity

- Ion channel activity

- Kinase activity

- Kinase regulator activity

- Ligand-dependent nuclear receptor activity

- Ligase activity

- Lipid kinase activity

- Lipid phosphatase activity

- Molecular function unknown

- Oxidoreductase activity

- Peptidase activity

- Protein binding

- Protein serine/threonine kinase activity

- Protein-tyrosine kinase activity

- Receptor activity

- Receptor binding

- Receptor signaling complex scaffold activity

- Receptor signaling protein serine/threonine kinase activity

- Receptor signaling protein tyrosine phosphatase activity

- RNA binding

- RNA-directed DNA polymerase activity

- Structural constituent of cytoskeleton

- Sugar-phosphatase activity

- Transcription factor activity

- Transcription regulator activity

- Transferase activity

- Translation regulator activity

- Transmembrane receptor activity

- Transmembrane receptor protein tyrosine kinase activity

- Transporter activity

- Voltage-gated ion channel activity

Identified targets are categorized into 19 different primary and alternate sub-cellular localizations:- Cell surface- Centrosome- Clathrin-coated vesicle- Cytoplasm- Cytoplasmic vesicle- Cytosol- Endoplasmic reticulum- Endosome- Extracellular- Golgi apparatus- Integral to membrane- Lysosome- Mitochondrial membrane
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cleveland Clinic Lou Ruvo Center for Brain Health and MedAvante Announce Alliance
2. MicroVention Announces First Patient Enrollment In Clinical Trial To Compare Coiling Technologies For Treating Brain Aneurysms
3. Research Shows Improved Brain Performance With Citicoline
4. Hamamatsus NanoZoomer whole-slide scanners play a critical role in CSHLs Mouse Brain Architecture Project
5. Brain Research Foundation Announces Grant To Study Concussive Events Among Grade School Children
6. Interim Results Reported for Phase I Open-Label Clinical Trial for the Treatment of PTSD and MDD Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™
7. Brainybrawn, Inc. announces Launch of its Web based Medical College Information Management Solution (Sanvi MCIMS), as well as Receipt of Order for Its Comprehensive Restaurant Information Management Solution for Managing Chain of Restaurants (Sanvi
8. Results Reported for Phase Ib Open-Label Clinical Trial for the Treatment of Depression Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™
9. Elekta, pioneer in treatment of cancer in brain disorders, to Move North America Headquarters to Atlanta
10. Ampio Advances NCE001 Cancer Drug into Preclinical Development Following Successful Recent Financing and the Granting of Patents in USA, Canada, Europe and China
11. Siteman Cancer Center at Barnes-Jewish and Washington University Begins Imaging with First ViewRay System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... May 24, 2013  An international roster of experts ... 18, in Santa Monica, Calif. , ... therapies for MPM, a rare form of cancer that ... pleura, the lining of the chest. Hosted ... Institute, the 3rd Annual International Symposium on Lung-Sparing Therapies ...
(Date:5/24/2013)... May 24, 2013 China Biologic Products, Inc. ... fully integrated plasma-based biopharmaceutical company in China ... learned from a public announcement issued by Shanghai RAAS ... listed on Shenzhen Stock Exchange, that on May 21, ... ("Ms. Chan"), one of the shareholders of the Company, ...
(Date:5/24/2013)... 24, 2013 In accordance with Rule 17.1 and ... of the United States Exchange Act, Echo Pharma Acquisition Limited ... Elan Corporation (NYSE: ELN). Background On ... an offer for the entire of the issued and to ... "Original Offer").  On 20 May 2013, Royalty ...
Breaking Medicine Technology:International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 2International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 2Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 3Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 5Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 6Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 7Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 8Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 9
... Masimo (Nasdaq: MASI ... showcasing Masimo noninvasive patient monitoring technologies were presented last ... Annual Meeting in San Diego, California.  The largest ... Meeting provides an important platform for previewing the latest ...
... Wash., Oct. 27 The International Foundation for ... announce the forthcoming release of the mSCAN (mobile ... (Sonography Clinical Assessment Notebook), was developed by IFSER ... for clinical assessment tools in sonography. Based on ...
Cached Medicine Technology:Over 20 New Clinical Studies Presented on Masimo Noninvasive Patient Monitoring Technologies at the American Society of Anesthesiologists Annual Meeting 2Over 20 New Clinical Studies Presented on Masimo Noninvasive Patient Monitoring Technologies at the American Society of Anesthesiologists Annual Meeting 3Over 20 New Clinical Studies Presented on Masimo Noninvasive Patient Monitoring Technologies at the American Society of Anesthesiologists Annual Meeting 4Over 20 New Clinical Studies Presented on Masimo Noninvasive Patient Monitoring Technologies at the American Society of Anesthesiologists Annual Meeting 5Over 20 New Clinical Studies Presented on Masimo Noninvasive Patient Monitoring Technologies at the American Society of Anesthesiologists Annual Meeting 6Over 20 New Clinical Studies Presented on Masimo Noninvasive Patient Monitoring Technologies at the American Society of Anesthesiologists Annual Meeting 7Over 20 New Clinical Studies Presented on Masimo Noninvasive Patient Monitoring Technologies at the American Society of Anesthesiologists Annual Meeting 8Over 20 New Clinical Studies Presented on Masimo Noninvasive Patient Monitoring Technologies at the American Society of Anesthesiologists Annual Meeting 9IFSER: Introducing the mSCAN 2
(Date:5/24/2013)... 2013 ShopPharmacyCounter.com PhenObestin 37.5 Summer Sale ... announced price reductions on their popular PhenObestin 37.5 non-prescription ... clients to lose weight as effortlessly as possible has ... more than 50%. , Bottles have been reduced from ... all orders will receive free shipping. , Made ...
(Date:5/24/2013)... you start the grill, before you watch the game, kick back ... Kotb on the Today Show on Memorial Day. Carley Knobloch, ... and Hoda, including the new LawnBott® LB75 robotic mower. ... military who made the ultimate sacrifice for us. On Memorial ... family and enjoy the day. With a LawnBott® robotic mower, ...
(Date:5/24/2013)... (HealthDay News) -- Patients hospitalized for heart failure appear ... on Mondays or in the morning, a new study ... highest among heart failure patients admitted in January, on ... scheduled to present their findings Saturday in Portugal at ... the European Society of Cardiology. "The fact ...
(Date:5/24/2013)... RI (PRWEB) May 24, 2013 With Memorial ... why Amica Insurance is offering tips to help ... National Fire Protection Association (NFPA) reports that gas ... 2006 and 2010. Charcoal or other solid-fueled grills, meanwhile, caused ... , As a result, Amica Insurance is sharing the following ...
(Date:5/24/2013)... Calif.) (PRWEB) May 24, 2013 ... House Appropriators and the California congressional delegation, joined ... restore sequestered industry user fees paid to the ... to ensure that future across-the-board cuts will not ... of the FY14 Agriculture, Rural Development and FDA ...
Breaking Medicine News(10 mins):Health News:ShopPharmacyCounter.com PhenObestin 37.5 Summer Sale Now On 2Health News:LawnBott® Visits the Today Show with Kathie Lee and Hoda 2Health News:Monday Best Time for Hospitalization With Heart Failure, Study Says 2Health News:Don’t Get Burned: Five Grilling Tips from Amica Insurance 2Health News:California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 2Health News:California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 3
... CHENGDU, China, May 20 /Xinhua-PRNewswire-FirstCall/ -- Tianyin,Pharmaceutical, Co., ... of modernized traditional Chinese medicine ("TCM") based in,Chengdu, ... new distribution,agreements with a total of 15 regional ... Many of these agreements, which are for a ...
... iron therapies, SAN ANTONIO, May 20 Mission ... oral iron supplement for,treatment of iron deficiency anemia (IDA) ... depletion of stored iron that prevents maturation of red,blood ... as well as,essential vitamins and minerals to help patients ...
... Health IT Solutions Recognized, BOSTON, May 20 ... TEPR Awards honorees during the Opening Session of,the ... Conference in,Ft. Lauderdale, Florida., TEPR Awards annually ... and solutions. The 2008 TEPR Awards honorees,are:, ...
... for healthy women entering the menopause. , HRT in the ... the first few years of the menopause who need HRT ... This is the conclusion and clinical advice of the First ... on March 29th and 30th, 2008. , The Zrich Summit ...
... May 18, 2008 TAP Pharmaceutical Products ... studies evaluating investigational new drug TAK-390MR, the first proton ... technology, in healing patients with erosive esophagitis (EE) and ... at the Digestive Disease Week (DDW) annual meeting in ...
... Ratify E&Y and Approve Charter Amendment; ... Board Re-appoints Leadership, CHICAGO, May ... said today that its Board of Directors declared,a regular quarterly dividend ... stockholders of record on June 4, 2008. The dividend is the,second ...
Cached Medicine News:Health News:Tianyin Pharmaceutical Signs Over 60 New Distribution Agreements with 15 Regional Distributors 2Health News:Tianyin Pharmaceutical Signs Over 60 New Distribution Agreements with 15 Regional Distributors 3Health News:Mission Pharmacal Launches Ferralet(R) 90 for Treatment of the Leading Cause of Anemia in the U.S. 2Health News:Mission Pharmacal Launches Ferralet(R) 90 for Treatment of the Leading Cause of Anemia in the U.S. 3Health News:2008 TEPR Awards Honorees Announced 2Health News:Global menopause summit concludes HRT is safe for healthy women entering menopause 2Health News:Global menopause summit concludes HRT is safe for healthy women entering menopause 3Health News:TAK-390MR Phase 3 data presented at Digestive Disease Week 2Health News:TAK-390MR Phase 3 data presented at Digestive Disease Week 3Health News:TAK-390MR Phase 3 data presented at Digestive Disease Week 4Health News:Ventas Declares Regular Quarterly Dividend of $0.5125 Per Share 2Health News:Ventas Declares Regular Quarterly Dividend of $0.5125 Per Share 3Health News:Ventas Declares Regular Quarterly Dividend of $0.5125 Per Share 4Health News:Ventas Declares Regular Quarterly Dividend of $0.5125 Per Share 5
... This antimicrobial skin cleanser will not leave ... with frequent washings. With persistent Antimicrobial action, ... of microorganisms, including gram-negative and gram-positive bacteria, ... as a 15 second hand wash. The ...
... Prep Pads prepares the skin for improved ... dry, it leaves a thin film on ... surface and a barrier for natural body ... a dressing or tape. Skin Protectant is ...
... Povidone Iodine Prep Pads ... surface pathogens including bacteria, ... yeast. Povidone Iodine is ... wounds or mucus membranes. ...
Aplicare's Prep Pads offer convenience, low cost, ease of use. The medium size is appropriate for most applications. Each package is terminally sterilized, ensuring the safest possible product for th...
Medicine Products: